Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 23, 2022

Primary Completion Date

October 15, 2023

Study Completion Date

December 4, 2023

Conditions
Acute Myeloid LeukemiaMyeloproliferative Syndrome
Interventions
DRUG

CPX-351

"Induction : patients will receive induction treatment with CPX-351 100 U/m2 on days 1, 3, and 5. Patients who fail to achieve CR/CRi after the induction cycle will be offered a second induction course of CPX-351 100 U/m2 on days 1 and 3, at the investigators' discretion. If CR/CRi is not achieved following the second induction cycle, patients will go off study~Consolidation : patients in CR/CRi after induction cycle will receive up to 2 course of consolidation therapy with CPX-351 65 U/m2 on days 1 and 3. CPX351 doses could be reduced to 65 U/m2 on day 1 in case of unacceptable toxicity following the previous course.~Allo-SCT : patients for whom an allo-SCT is planned will receive a maximum of one consolidation cycle"

Trial Locations (34)

13000

MARSEILLE - Institut Paoli-Calmettes, Marseille

14033

CAEN - CHU Caen - IHBN, Caen

29609

BREST - Hôpital Morvan, Brest

30029

NIMES - CHU Caremeau, Nîmes

31059

Toulouse - IUCT Oncopole - Service d'Hématologie, Toulouse

33600

BORDEAUX - Hôpital Haut-Levêque, Pessac

34295

MONTPELLIER - Hôpital Saint-Eloi - Hématologie Clinique, Montpellier

35033

RENNES - Hôpital Pontchaillou - Hématologie, Rennes

37000

TOURS - Hôpital Bretonneau, Tours

38043

Grenoble - CHUGA - Hématologie Clinique, Grenoble

44093

NANTES - Hôpital Hôtel Dieu - Hématologie Clinique, Nantes

44100

ORLEANS - CHR - Hématologie, Orléans

49933

ANGERS - CHU - Maladies du sang, Angers

51100

REIMS - Hôpital Robert Debré - Hématologie Clinique, Reims

54500

NANCY - CHU de Brabois, Vandœuvre-lès-Nancy

59037

LILLE CHU - Hôpital Claude Huriez, Lille

63000

Clermont-Ferrand - Chu Estaing, Clermont-Ferrand

64109

BAYONNE - CH de la Côte Basque - Hématologie, Bayonne

67033

Strasbourg - Icans, Strasbourg

69008

LYON-Centre Léon Bérard, Lyon

69036

LYON HCL - CH Lyon Sud, Pierre-Bénite

75012

Paris St Antoine, Paris

75475

Paris Saint Louis, Paris

80054

AMIENS - CHU Amiens Picardie, Amiens

84000

AVIGNON - Centre Hospitalier, Avignon

86000

POITIERS - Hôpital La Milétrie - Hématologie Clinique, Poitiers

87042

LIMOGES - CHU Dupuytren 1, Limoges

92140

CLAMART - Hôpital d'Instruction des Armées de Percy, Clamart

93009

AVICENNE - Centre de Recherche Clinique, Bobigny

94000

CRETEIL - CHU Henri Mondor, Créteil

06189

NICE - Centre Antoine Lacassagne, Nice

06202

NICE - CHU - Hopital Archet 1, Nice

Unknown

VERSAILLES - Hôpital André Mignot, Versailles

Institut Gustave Roussy, Villejuif

All Listed Sponsors
collaborator

Acute Leukemia French Association

OTHER

collaborator

French Intergroup of Myeloproliferative syndromes

UNKNOWN

lead

French Innovative Leukemia Organisation

OTHER